The private and social costs of obesity have many causes, and their consequences can be grimly predicted with only rough accuracy. Among the most devastating is the increased incidence of diabetes, of which 60% can be directly attributed to weight gain. There are now about one billion people worldwide who are overweight or obese, compared with 850 million who are chronically underweight. It is estimated that the number of people worldwide with diabetes will increase from 175 million in 2000 to 353 million in 2030, with India and China together accounting for 24% of the total in 2050. Obesity and its economic costs are borne on three levels. At an individual level, obesity imposes costs by limiting personal opportunity in many ways, only some of which can be quantified. In the workplace (assuming the obese are employed, which they may not be, due in part to their condition), costs are borne by employers due to lost productivity, absences, underperformance, and higher insurance premia, which in the aggregate are quite large. Finally, obesity affects expenditures by local, state, and national governments, where programs compensate for or cover some of the private and workforce costs of illness and unemployment.

In 1919, John Maynard Keynes published his famous attack on the Carthaginian terms imposed on the Axis powers by the Treaty of Versailles at the end of World War I. The Economic Consequences of the Peace argued that punitive reparations would further bankrupt the vanquished, deepen their economic misery, and sow seeds of resentment to be exploited by political extremists. Sadly, Keynes was right, showing that economists can accurately forecast the costs if not the full effect of social dysfunction resulting from bad choices and lost opportunities.

The obesity epidemic also represents social dysfunction, although it is unlikely to lead to depression and war. Still, obesity is pernicious and destructive—the result of bad choices and lost opportunities on many levels. The private and social costs of obesity have many causes, and their consequences can be grimly predicted with only rough accuracy. Among the most devastating is the increased incidence of diabetes, of which 60% can be directly attributed to weight gain (1). As a recent commentary noted, “Overweight and obesity have become to diabetes what tobacco is to lung cancer” (2).

The objective of this review is to offer an economic perspective on the economic consequences of obesity. These consequences are quantified where data are available, although lack of data in many areas suggests that the estimates reported are probably lower bound. In addition to exploring various economic issues related to obesity, emphasis is given to the relationship between poverty and the obesity epidemic.

There are now about one billion people worldwide who are overweight or obese, compared with 850 million who are chronically underweight. It is estimated that the number of people worldwide with diabetes will increase from 175 million in 2000 to 353 million in 2030, with India and China together accounting for 24% of the total in 2050 (2). In offering a perspective on the economic consequences of the obese, I shall steer clear of causes, some of which are economic, but that also have biological, cultural, and political explanations that we do not fully understand. Yach et al. (2) summarize five developments that have led to rising obesity: 1) expanding labor market opportunities for women, 2) increased consumption of food away from home, 3) rising costs of healthy foods relative to unhealthy foods, 4) growing caloric intake with declining overall food prices, and 5) decreased occupational and environmental physical activity.

Obesity and its economic costs are borne on three levels, each related to the next. At an individual level, obesity imposes costs by limiting personal opportunity in many ways, only some of which can be quantified. Next, in the workplace (assuming the obese are employed, which they may not be, due in part to their condition), costs are borne by employers due to lost productivity, absences, underperformance, and higher insurance premia, which in the aggregate are quite large. Finally, obesity affects expenditures by local, state, and national governments, where programs compensate for or cover some of the private and workforce costs of illness and unemployment. These costs are shifted to programs such as Medical Assistance, unemployment insurance, state-run health insurance, Veterans hospitals, Medicare, and Medicaid, in effect pushing them onto present and future taxpayers.

The U.S. leads the world in rates of overweight and obese individuals per capita, estimated in 2004 at 64.5% of the population. Mexico is not far behind at 62.3%, and the U.K. and Australia rank third and fourth with 61 and 58.4%, respectively. Japan has the lowest rate (25.8%) and Korea the second lowest (30.6%) (3). Low rates of obesity constitute an important competitive advantage because they impose less drag on national productivity. Of particular concern is that these rates accelerated markedly in the 1990s after a period of stability in the 1980s, especially among children. According to the American Obesity Association (3), the percentage of obese children in the U.S. grew from 7% in 1976–1980 to 15.3% in 1999–2000. In some countries, type 2 diabetes accounts for 80% of all diabetes cases reported in the pediatric population (4,5).

Some economists have described obesity as a choice in which individuals trade off risks for convenience, similar to driving a car (6), and some economists have argued that obesity results from addictive eating behavior, composed of two factors: “reinforcement” and “tolerance.” Reinforcement results when past consumption increases the desire for present consumption. Tolerance implies that high levels of past consumption mean that present consumption produces lower marginal benefits, such as negative health effects. When reinforcement overcomes tolerance, and people weigh present pleasure more than future harm, addiction to food can be “rational ” (7). These “rational addiction” models are based on the claim that current consumption increases future demand for unhealthy foods largely through force of habit (8,9). If consumers value current consumption of these foods more than the future harm to their health, they may consistently choose to eat in ways that are harmful in the long run.

However, to call this choice “rational” is the sort of reasoning only a Chicago School economist could love (10). Indeed, a study of Native American nutrient intake testing this model found little support for it in a sample of Native Americans compared with non-Natives. The authors noted that “the thought that an entire class of individuals can make decisions without regard to future consequences is not only untenable, but contradicts the basic tenets of economic reasoning” (11).

To say that individuals are often myopic about the future consequences of current behavior is to state the obvious. But it does not seem rational to invite discomfort, discrimination, or lower wages and incomes. If driving a car is risky but convenient, what convenience, ease, and benefit can be equated at the margin with social ostracization, job loss, lower wages, earlier death, and chronic disease? Obesity has manifold individual implications, but nearly all of them are bad, denying people physical, social, and economic opportunities. To defend this process as a freely chosen tradeoff is to deny social responsibility in the name of individual responsibility and ignores the many failures of markets to provide for public health. Whatever individuals get in return for being obese cannot be worth the tradeoff unless they are largely indifferent to their physical, social, and economic welfare.

At a personal level, the negative impacts of obesity on physical health and attendant costs of morbidity and mortality are clear. Overall, health care costs for overweight and obese individuals are 37% higher than for people of normal weight, adding an extra $732 to the health care bill of each and every American (3,12). These added costs are almost equal to the health spending associated with smoking. One analyst finds that obesity has roughly the same association with chronic health conditions as 20 years of aging and is associated with a 36% increase in inpatient and outpatient spending and a 77% increase in medication costs. This compares with only a 21 and 28% increase in these costs for current smokers and even smaller effects for problem drinkers, despite the attention given to these other disorders (13). But apart from negative impacts on health, obesity also reduces the capacity of people to function effectively in finding and keeping jobs and truncates the earnings and wages they are likely to receive, especially for women (14).

In the workplace, employers of the overweight and obese confront these costs if they offer health insurance, but they also face costs of absenteeism, reduced productivity, and other complications. Obesity and obesity-related conditions, including heart disease, osteoarthritis, gallbladder disease, hypertension, and type 2 diabetes, result in $62.7 billion in doctors’ visits and $39.3 billion in lost workdays each year (15). Of these costs, by far the highest contributor is type 2 diabetes, which is estimated to add $98 billion per year in health care costs.

At the local, state, and federal level, where programs are responsible for health and welfare, numerous categories of insurance costs can be disaggregated. Based on the 1998 Medical Expenditure Panel Survey (MEPS), the 1996 and 1997 National Health Interview Surveys, and the National Health Accounts (NHA), these include out-of-pocket expenses, private insurance, Medicaid, and Medicare (12). These data are summarized in Table 1. Differences in the MEPS and NHA estimates are largely attributable to the inclusion of nursing home costs in the NHA estimates.

At the state level, the same researchers analyzed data from 1998 to 2000 using the Behavioral Risk Factor Surveillance System (BRFSS) to predict state medical spending attributable to obesity measured by a BMI >30 kg/m2 (16). These measures included only direct medical costs for Medicare and Medicaid, not indirect costs from absenteeism and decreased productivity. Data by state are shown in Table 2. The average state share of total medical expenses directly attributable to obesity was 5.7%, totaling $75 billion in 1998. Obesity accounted for an average of 6.8% of Medicare costs, totaling $17 billion, and 10.6% of Medicaid costs, totaling $21.3 billion.

There is strong cross-sectional and case study evidence showing that these indirect costs may be far more important than direct medical care costs. A recent review (17) estimated, based on their work in China, that in 2000 the direct and indirect costs of overweight and obese adults was nearly $50 billion U.S. dollars, of which 12% was direct and 88% indirect. By 2025, they projected these costs would rise to $112 billion, of which 5% will be direct and 95% indirect.

One of the most difficult aspects of obesity's economic consequences is the two-way connection from obesity to income levels and poverty. While obesity denies individuals economic opportunity, it is abundantly clear that a lack of economic opportunity increases the likelihood of becoming obese. In many countries in the developing world, reductions in calories as a response to economic privation is a last resort, afflicting mainly those at the edge of subsistence, living on a dollar or two a day (18). For the rest, and for nearly everyone in the OECD (Organisation for Economic Co-operation and Development) countries, household spending on food is such that budget constraints are not likely to reduce total calories consumed—in fact, quite the opposite.

In a series of empirical studies, Drewnowski et al. (1921) show that a budget constraint on possible food spending causes households to alter the composition of foods in the direction of more calorie-dense sugars, fats, and carbohydrates and away from lean meat, fish, cheese, vegetables, and fruit. Noting “a persistent belief that low-income consumers have made wrong or inappropriate food choices and need to be educated, taught, or motivated to behave otherwise,” they noted that this paternalistic view ignores the real choices and trade-offs the poor must make (19). In fact, food choices by poor consumers may simply reflect the most cost-effective way to purchase calories. But instead of purchasing an amount appropriate to healthy weight, the basket of foods chosen can easily overshoot calorically if composed of these dense, often highly palatable, foods.

In Latin America and the Caribbean, the World Health Organization estimated the combined annual direct and indirect costs of diabetes, much of it obesity-related, at $65.2 billion in 2000. In Mexico, 138 deaths per 100,000 from diabetes in adults aged 20–84 years in 2000 made it the leading cause of mortality, compared with 82 deaths per 100,000 from diabetes in the U.S., according to the National Institute of Geographic and Statistical Information. Diabetes prevalence in Mexico is among the highest in the world, at 10.7% of adults aged 20–69 years. Poor families in Latin America, according to the International Diabetes Federation, are further impoverished because 40–60% of their care is paid out of household income, and most poor families are uninsured (22).

It is also clear, based on large panel surveys, that obesity is more prevalent in the U.S. among groups with lower levels of education and income (23,24). At the state level, or as measured by congressional districts, the highest rates of obesity are found in the lowest income areas (25,26). Aggregate census data also support the finding that the proportion of families living in poverty is strongly correlated with higher neighborhood rates of obesity and type 2 diabetes (27). Both domestically and internationally, the cruel causation of poverty and obesity thus runs both ways—to be poor is often to be obese and vice versa.

Although obesity is costly for both individuals and society, government action alone is likely to be insufficient in reversing current trends without substantial changes in private behavior. We may retrace the three levels at which obesity imposes costs in order to see how actions at each level may reduce them. At an individual level, a variety of incentives may be needed to encourage healthier behavior (some of which are economic), such as insurance premium adjustments for those maintaining ideal body weights and a return in schools and workplaces to diet and exercise as key parts of the school and work day.

In the workplace itself, there is increasing recognition by employers and their insurers that both exercise and diet should be internalized as “part of the job.” In Minnesota, Blue Cross/Blue Shield has announced a program to be subsidized largely out of funds received in its tobacco settlement for workplace wellness and fitness programs integrated with diet and the redesign of the built workplace environment to encourage physical motion (28). In one study of a large international company, Goetzel et al. (29) calculated that if such programs could achieve reductions in health risks of only 0.17% a year for 10 years, the investment would break even. If insurance companies were prepared to reward such investments at modest levels with reduced premia, the break-even result could occur almost immediately, and positive returns would quickly flow to the bottom line. The Oxford Health Alliance (30) estimates an average return of $3.00 for every $1.00 invested in such programs, which can rise as they are more optimally targeted and designed.

As individual and workplace decisions change, the costs cascading into the public health and welfare system will also lessen, resulting in lower burdens to taxpayers from Medical Assistance, unemployment insurance, state-run health insurance programs, Medicare, and Medicaid. However, since these programs disproportionately involve the poor and unemployed, who are more likely to be obese and diabetic, the burden to society is unlikely to be reduced as a direct pass-through. Hence, public policies are especially important in breaking the obesity-poverty link, not just by lecturing the poor on their miscreance but bringing them out of poverty and into the active workforce, where they are more likely to be able and willing to respond to private and workplace incentives to improve their health and productivity. Working at obesity and diabetes from the poverty end of the connection, especially among groups heavily burdened by these afflictions, such as Native Americans, is thus rewarding in multifaceted ways often unappreciated by the medical establishment.

Finally, the argument for recognizing and responding to the economic consequences of the obese relates in important ways to international competitiveness. By dragging down rates of productivity and siphoning off resources that could otherwise be invested in education, technology, social improvements, and private capital formation, obesity and diabetes hobble even robust economies, such as those of the U.S. and China. In poorer developing countries, their impact is even more manifestly immiserising. Every nation thus has a competitive incentive to respond to these challenges in the interest of economic growth and the welfare of future generations.

In conclusion, the economic consequences of obesity are serious and growing, like the incidence of obesity itself. These consequences are no longer the province of wealthy industrialized countries (some of which, like Japan, have very low rates) and increasingly burden lower-income countries with added health care costs and lost productivity. Unless a major effort is undertaken to confront the complex factors that have contributed to these trends, valuable resources will be drawn away from more productive economic activities, with particularly negative consequences for the poor.

TABLE 1

Aggregate medical spending, in billions of dollars, attributable to overweight and obesity, by insurance status and data source, 1996–1998

Overweight and obesity
Obesity
MEPS (1998)NHA (1998)MEPS (1998)NHA (1998)
Insurance category     
    Out-of-pocket $7.1 $12.8 $3.8 $6.9 
    Private $19.8 $28.1 $9.5 $16.1 
    Medicaid $3.7 $14.1 $2.7 $10.7 
    Medicare $20.9 $23.5 $10.8 $13.8 
Total $51.5 $78.5 $26.8 $47.5 
Overweight and obesity
Obesity
MEPS (1998)NHA (1998)MEPS (1998)NHA (1998)
Insurance category     
    Out-of-pocket $7.1 $12.8 $3.8 $6.9 
    Private $19.8 $28.1 $9.5 $16.1 
    Medicaid $3.7 $14.1 $2.7 $10.7 
    Medicare $20.9 $23.5 $10.8 $13.8 
Total $51.5 $78.5 $26.8 $47.5 

Note: Calculations based on data from the 1998 Medical Expenditure Panel Survey (MEPS) merged with the 1996 and 1997 National Health Interview Surveys and health care expenditures data from NHA. MEPS estimates do not include spending for institutionalized populations, including nursing home residents. Adapted and reprinted from ref. 13.

TABLE 2

Estimated percentage of total medical expenses and Medicare and Medicaid costs attributable to obesity, by state (Behavioral Risk Factor Surveillance System 1998–2000)

Total population (%)Millions of dollarsMedicare
Medicaid
Population (%)Millions of dollarsPopulation (%)Millions of dollars
State       
    Alabama 6.3 $1,320 7.7 $341 9.9 $269 
    Alaska 6.7 $195 7.7 $17 8.2 $29 
    Arizona 4.0 $752 3.9 $154 13.5* $242 
    Arkansas 6.0 $663 7.0 $171 11.5 $180 
    California 5.5 $7,675 6.1 $1,738 10.0 $1,713 
    Colorado 5.1 $874 5.1 $139 8.7 $158 
    Connecticut 4.3 $856 6.5 $246 11.0 $419 
    Delaware 5.1 $207 9.8 $57 13.8 $66 
    District of Columbia 6.7 $372 6.5 $64 12.5 $114 
    Florida 5.1 $3,987 6.1 $1,290 11.6 $900 
    Georgia 6.0 $2,133 7.1 $405 10.1 $385 
    Hawaii 4.9 $290 4.8 $30 11.2 $90 
    Idaho 5.3 $227 5.6 $40 12.0 $69 
    Illinois 6.1 $3,439 7.8 $805 12.3 $1,045 
    Indiana 6.0 $1,637 7.2 $379 15.7 $522 
    Iowa 6.0 $783 7.5 $165 9.4 $198 
    Kansas 5.5 $657 6.4 $138 10.2* $143 
    Kentucky 6.2 $1,163 7.5 $270 11.4 $340 
    Louisiana 6.4 $1,373 7.4 $402 12.9 $525 
    Maine 5.6 $357 5.7 $66 10.7 $137 
    Maryland 6.0 $1,533 7.7 $368 12.9 $391 
    Massachusetts 4.7 $1,822 5.6 $446 7.8 $618 
    Michigan 6.5 $2,931 7.8 $748 13.2 $882 
    Minnesota 5.0 $1,307 6.6 $227 8.6 $325 
    Mississippi 6.5 $757 8.1 $223 11.6 $221 
    Missouri 6.1 $1,636 7.1 $413 11.9 $454 
    Montana 4.9 $175 6.2 $41 9.8 $48 
    Nebraska 5.8 $454 7.0 $94 10.3 $114 
    Nevada 4.8 $337 5.0 $74 10.1* $56 
    New Hampshire 5.0 $302 5.4 $46 8.6* $79 
    New Jersey 5.5 $2,342 7.1 $591 9.8 $630 
    New Mexico 4.8 $324 4.6 $51 8.5 $84 
    New York 5.5 $6,080 6.7 $1,391 9.5 $3,539 
    North Carolina 6.0 $2,138 7.0 $448 11.5 $662 
    North Dakota 6.1 $209 7.7 $45 11.7 $55 
    Oklahoma 6.0 $854 7.0 $227 9.9 $163 
    Ohio 6.1 $3,304 7.7 $839 10.3 $914 
    Oregon 5.7 $781 6.0 $145 8.8 $180 
    Pennsylvania 6.2 $4,138 7.4 $1,187 11.6 $1,219 
    Puerto Rico 7.4  8.1  10.1  
    Rhode Island 5.2 $305 6.5 $83 7.7 $89 
    South Carolina 6.2 $1,060 7.7 $242 10.6 $285 
    South Dakota 5.3 $195 5.9 $36 9.9 $45 
    Tennessee 6.4 $1,840 7.6 $433 10.5 $488 
    Texas 6.1 $5,340 6.8 $1,209 11.8 $1,177 
    Utah 5.2 $393 5.8 $62 9.0 $71 
    Vermont 5.3 $141 6.9 $29 8.6 $40 
    Virginia 5.7 $1,641 6.7 $320 13.1 $374 
    Washington 5.4 $1,330 6.0 $236 9.9 $365 
    West Virginia 6.4 $588 7.3 $140 11.4 $187 
    Wisconsin 5.8 $1,486 7.7 $306 9.1 $320 
    Wyoming 4.9 $87 5.9 $15 8.5 $23 
Total 5.7 $75,051 6.8 $17,701 10.6 $21,329 
Total population (%)Millions of dollarsMedicare
Medicaid
Population (%)Millions of dollarsPopulation (%)Millions of dollars
State       
    Alabama 6.3 $1,320 7.7 $341 9.9 $269 
    Alaska 6.7 $195 7.7 $17 8.2 $29 
    Arizona 4.0 $752 3.9 $154 13.5* $242 
    Arkansas 6.0 $663 7.0 $171 11.5 $180 
    California 5.5 $7,675 6.1 $1,738 10.0 $1,713 
    Colorado 5.1 $874 5.1 $139 8.7 $158 
    Connecticut 4.3 $856 6.5 $246 11.0 $419 
    Delaware 5.1 $207 9.8 $57 13.8 $66 
    District of Columbia 6.7 $372 6.5 $64 12.5 $114 
    Florida 5.1 $3,987 6.1 $1,290 11.6 $900 
    Georgia 6.0 $2,133 7.1 $405 10.1 $385 
    Hawaii 4.9 $290 4.8 $30 11.2 $90 
    Idaho 5.3 $227 5.6 $40 12.0 $69 
    Illinois 6.1 $3,439 7.8 $805 12.3 $1,045 
    Indiana 6.0 $1,637 7.2 $379 15.7 $522 
    Iowa 6.0 $783 7.5 $165 9.4 $198 
    Kansas 5.5 $657 6.4 $138 10.2* $143 
    Kentucky 6.2 $1,163 7.5 $270 11.4 $340 
    Louisiana 6.4 $1,373 7.4 $402 12.9 $525 
    Maine 5.6 $357 5.7 $66 10.7 $137 
    Maryland 6.0 $1,533 7.7 $368 12.9 $391 
    Massachusetts 4.7 $1,822 5.6 $446 7.8 $618 
    Michigan 6.5 $2,931 7.8 $748 13.2 $882 
    Minnesota 5.0 $1,307 6.6 $227 8.6 $325 
    Mississippi 6.5 $757 8.1 $223 11.6 $221 
    Missouri 6.1 $1,636 7.1 $413 11.9 $454 
    Montana 4.9 $175 6.2 $41 9.8 $48 
    Nebraska 5.8 $454 7.0 $94 10.3 $114 
    Nevada 4.8 $337 5.0 $74 10.1* $56 
    New Hampshire 5.0 $302 5.4 $46 8.6* $79 
    New Jersey 5.5 $2,342 7.1 $591 9.8 $630 
    New Mexico 4.8 $324 4.6 $51 8.5 $84 
    New York 5.5 $6,080 6.7 $1,391 9.5 $3,539 
    North Carolina 6.0 $2,138 7.0 $448 11.5 $662 
    North Dakota 6.1 $209 7.7 $45 11.7 $55 
    Oklahoma 6.0 $854 7.0 $227 9.9 $163 
    Ohio 6.1 $3,304 7.7 $839 10.3 $914 
    Oregon 5.7 $781 6.0 $145 8.8 $180 
    Pennsylvania 6.2 $4,138 7.4 $1,187 11.6 $1,219 
    Puerto Rico 7.4  8.1  10.1  
    Rhode Island 5.2 $305 6.5 $83 7.7 $89 
    South Carolina 6.2 $1,060 7.7 $242 10.6 $285 
    South Dakota 5.3 $195 5.9 $36 9.9 $45 
    Tennessee 6.4 $1,840 7.6 $433 10.5 $488 
    Texas 6.1 $5,340 6.8 $1,209 11.8 $1,177 
    Utah 5.2 $393 5.8 $62 9.0 $71 
    Vermont 5.3 $141 6.9 $29 8.6 $40 
    Virginia 5.7 $1,641 6.7 $320 13.1 $374 
    Washington 5.4 $1,330 6.0 $236 9.9 $365 
    West Virginia 6.4 $588 7.3 $140 11.4 $187 
    Wisconsin 5.8 $1,486 7.7 $306 9.1 $320 
    Wyoming 4.9 $87 5.9 $15 8.5 $23 
Total 5.7 $75,051 6.8 $17,701 10.6 $21,329 
*

Estimates based on fewer than 20 observations. Adapted and reprinted from ref. 17.

Published ahead of print at http://diabetes.diabetesjournals.org on 29 June 2007. DOI: 10.2337/db07-0633.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1.
James W, Jackson-Leach R, Mhurchu CN, Kalamara E, Shayeghi M, Rigby NJ, Nishida C, Rodgers A: Overweight and obesity (high body mass index). In
Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Risk Factors.
Geneva, World Health Org.,
2003
,p.
497
–596
2.
Yach D, Stuckler S, Brownell D: Epidemiological and economic consequences of the global epidemics of obesity and diabetes.
Nat Med
12
:
62
–66,
2006
3.
Loureiro ML: Obesity: economic dimensions of a ‘super size’ problem.
Choices
 (
3rd Quarter
):
1
–5,
2004
4.
Type 2 diabetes in children and adolescents: American Diabetes Association.
Pediatrics
105
:
671
–680,
2000
5.
Cockram C: The epidemiology of diabetes mellitus in the Asia-Pacific region.
Hong Kong Med J
6
:
43
–52,
2000
6.
Lakdawalla D, Philipson T: The growth of obesity and technological change: a theoretical and empirical examination. National Bureau of Economic Research, Working Paper no. 8946,
2002
7.
Becker GS, Grossman M, Murphy KM: Rational addiction and the effect of price on consumption. In
Choice Over Time.
Loewenstein G, Elster J, Eds. New York, Russell Sage Foundation,
1992
,p.
361
–370
8.
Becker GS, Murphy KM: A theory of rational addiction.
J Polit Econ
96
:
675
–700,
1988
9.
Iannacone LR: Addiction and satiation.
Econ Let
21
:
95
–99,
1986
10.
Sen AK: Rational fools: a critique of the behavioral foundations of economic theory.
Philos Public Aff
6
:
317
–344,
1977
11.
Richardson TJ, Patterson PM: Native American obesity: an economic model of the ‘thrifty gene’ theory.”
Am J Agric Econ
88
:
542
–560,
2006
12.
Finkelstein EA, Fiebelkorn IC, Wang G: National medical spending attributable to overweight and obesity: how much, and who's paying?
Health Aff
219
–226,
2003
13.
Sturm R: The effects of obesity, smoking, and drinking on medical problems and costs.
Health Aff
21
:
245
–253,
2002
14.
Cawley J: The impact of obesity on wages.
J Hum Resour
39
:
451
–474,
2004
15.
Economic impact of obesity [Article online],
2007
. Available from http://www.obesityinamerica.org/economicimpact.html. Accessed 21 February 2007
16.
Finkelstein EA, Fiebelkorn IC, Wang G: State-level estimates of annual medical expenditures attributable to obesity.
Obes Res
12
:
18
–24,
2004
17.
Popkin BM, Kim S, Rusev ER, Zizza C: Measuring the full economic costs of diet, physical activity and obesity-related chronic diseases.
Obes Rev
7
:
271
–293,
2006
18.
Runge CF, Senauer B, Pardey P, Rosegrant M:
Ending Hunger in Our Lifetime: Food Security and Globalization.
Baltimore, Johns Hopkins University Press,
2003
19.
Drewnowski A, Darmon N: Food choices and diet costs: an economic analysis.
J Nutr
135
:
900
–904,
2005
20.
Drewnowski A: Energy density, palatability, and satiety: implications for weight control.
Nutr Rev
56
:
347
–353,
1998
21.
Drewnowski A, Darmon N, Briend A: Replacing fats and sweets with vegetables and fruit: a question of cost.
Am J Public Health
94
:
1555
–1559,
2004
22.
Barclay E: In Mexico, diabetes strains lives and budgets.
New York Times
, 12 June 2007: section F, p.
6
23.
Paeratakul S, Lovejoy JC, Ryan DH, Bray GA: The relation of gender, race and socioeconomic status to obesity and obesity comorbidities in a sample of U.S. adults.
Int J Obes Relat Metab Disord
26
:
1205
–1210,
2002
24.
Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among U.S. adult, 1999–2000.
J Am Med Assoc
288
:
1723
–1727,
2002
25.
Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS: Prevalence of obesity, diabetes and obesity-related health risk factors.
J Am Med Assoc
289
:
76
–79,
2003
26.
New York Department of Health: New York City Community Health Profiles [Article online, cited in ref.
19 
],
2004
. Available from www.nyc.gov/html/doh/htmsl/data/data.html. Accessed June 2004
27.
Drewnowski A, Rehm C, Solet D: Disparities in obesity rates: analysis by ZIP code area.
Soc Sci Med.
2007
Aug 28 [Epub ahead of print]
28.
Levine JA, Eberhardt NL, Jensen MD: Role of nonexercise activity thermogenics in resistance to fat gain in humans.
Science
283
:
212
–214,
1999
29.
Goetzel RZ, Ozminkowski RJ, Baase CM, Billotti GM: Estimating the return-on-investment from changes in employee health risks on the Dow Chemical Company's health care costs.
J Occup Environ Med
47
:
759
–768,
2005
30.
Oxford Health Alliance Working Group: Economic Consequences of Chronic Diseases and the Economic Rationale for Public and Private Intervention. London, Oxford Health Alliance,
2005